Skin cancer is reaching epidemic levels in the United States. Recent advances in the understanding of the pathophysiology of melanoma have allowed improved risk stratification in the revised American Joint Committee on Cancer (AJCC) criteria, new tests to capture patients at higher risk than their stage may indicate, and new treatments to offer hope and cures to patients with advanced disease.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.det.2018.08.003 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!